Supplementary Figures S1-S11 from Monomer Preference of EGFR Tyrosine Kinase Inhibitors Influences the Synergistic Efficacy of Combination Therapy with CetuximabAyano Oashi, Kenzo Soejima, Tadashi Manabe et al.|Unknown|2023Cited by 0
Supplementary Fig. S2 from Overcoming EGFR Bypass Signal-Induced Acquired Resistance to ALK Tyrosine Kinase Inhibitors in ALK-Translocated Lung CancerMasayoshi Miyawaki, Kenzo Soejima, Hiroyuki Yasuda et al.|Unknown|2023Cited by 0
Supplementary Fig. S1 from Overcoming EGFR Bypass Signal-Induced Acquired Resistance to ALK Tyrosine Kinase Inhibitors in ALK-Translocated Lung CancerMasayoshi Miyawaki, Kenzo Soejima, Hiroyuki Yasuda et al.|Unknown|2023Cited by 0
Data from Activation of EGFR Bypass Signaling by TGFα Overexpression Induces Acquired Resistance to Alectinib in <i>ALK</i>-Translocated Lung Cancer CellsTetsuo Tani, Kenzo Soejima, Hiroyuki Yasuda et al.|Unknown|2023Cited by 0
Data from Monomer Preference of EGFR Tyrosine Kinase Inhibitors Influences the Synergistic Efficacy of Combination Therapy with CetuximabAyano Oashi, Kenzo Soejima, Hiroyuki Yasuda et al.|Unknown|2023Cited by 0